Skip to main content

Animations

MJFF Publications

7221 - 7230 of 8785 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2017
  • 2025
  • 2019
  • 2021
  • 2018
  • 2022
  • 2016
  • 2020
  • Summary Details
    OPEN
    Title: The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20180248
    Citation Count: 199
  • Summary Details
    OPEN
    Title: Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0203659
    Citation Count: 70
  • Summary Details
    OPEN
    Title: The Mitochondrial Rhomboid Protease PARL Is Regulated by PDK2 to Integrate Mitochondrial Quality Control and Metabolism
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.celrep.2017.01.029
    Citation Count: 78
  • Summary Details
    RESTRICTED
    Title: Differential associations between retro walking versus forward walking, axial motor features and body composition in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107924
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Complementary motivational roles of nigroaccumbens and nigrostriatal dopaminergic pathways
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27504
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson’s disease
    Journal Name: Brain and Behavior
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/brb3.2086
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1286-2
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Pathogenic Mechanisms of Cytosolic and Membrane-Enriched α-Synuclein Converge on Fatty Acid Homeostasis
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1523/jneurosci.1881-21.2022
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.06.003
    Citation Count: 22
  • Summary Details
    OPEN
    Title: The effect of LRRK2 loss-of-function variants in humans
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-020-0893-5
    Citation Count: 103
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.